ClinicalTrials.gg
RecruitingNCT06176144Updated Jun 4, 2024

Impact of Desflurane and Sevoflurane on Postoperative Delirium in Elderly Patients

An interventional study of Desflurane and Sevoflurane in Delirium and Postoperative Cognitive Dysfunction, sponsored by West China Hospital. Recruiting at 1 site in China. Open to participants aged 65 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-06-04.

Sponsored by West China Hospital · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2025, 1 year 4 months ago, but the record still lists the study as recruiting.
  • Started Sep 2023; still recruiting 3 years 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
890
Allocation
Randomized
Ages
65 Years to 90 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 96 studies in Delirium with a site in China — 29 open to participants now, 30 under way, none of them phase 3. Delirium · China.

Planned enrollment
13th of 66
890 · median 262
Started
2023
with 6 others
No phase
40 of 96
13 open now
Primary completion
2025-07
later than 7 of 29 live
Registered
68th of 96
by date
Lead sponsor
3 of 96
West China Hospital

Among the 96 studies in Delirium with a site in China, this one is the 13th largest by planned enrollment of the 66 interventional ones that give a count, is one of 7 that started in 2023, is one of 40 with no phase, reaches primary completion later than 7 of the 29 other live ones, and was the 68th registered.

Delirium

935 studies on the registry are indexed under Delirium; 188 are open to participants now.

Browse Delirium studies →

Open to participants now

29 of the 96 studies in Delirium with a site in China are open now. Recruiting first, the newest first:

23 more — sign in →

All 29 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 124 Delirium studies recruiting now, 96 (77%) set no upper age limit and 8 (6%) stop at 75 or younger; 8 take children under 18; 14 take healthy volunteers.

This study: 65 Years to 90 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 96 studies in Delirium with a site in China, or all of them as a file.
02

Study summary

Advanced age is a consistent risk factor for the incidence of postoperative cognitive decline, which is associated with longer hospital stays, decreased quality of life, and increased mortality. Anaesthetic drugs can also affect postoperative cognition, as their residual effects can alter central nervous system activity. Desflurane and sevoflurane are widely used volatile anesthetics. Choice anesthetics may influence the occurrence of postoperative delirium. However, evidence in this aspect is conflicting.

Read the detailed description

With increasing life expectancy, more and more patients aged 65 or older will receive general anesthesia. Rapid recovery from anesthesia may reduce the incidence of many postoperative complications, such as postoperative delirium and cognitive dysfunction. Using inhalational anesthetics is the mainstay of general anesthesia. Since they pass readily into the brain, anesthetics are usually recognized as the important cause of postoperative cognitive dysfunction. Studies have shown that inhalation anesthesia may increase the risk of postoperative delirium in elderly patients compared to propofol, but such studies mostly focus on isoflurane and sevoflurane. Concentrations isoflurane caused aggregation of amyloid peptides in cell cultures, indicating that they brought cytotoxicity to the brain; sevoflurane also showed the same cytotoxic effect. However, some studies showed that inhalational anesthetics had a protective effect on postoperative cognitive function. Desflurane is currently known to be the least biotransformation inhaled anesthetic, whose blood-gas partition coefficient is only 0.42. Desflurane is increasingly used in elderly patients in clinical practice. However, it is not clear whether general anesthesia maintained mainly by desflurane reduces postoperative delirium and early cognitive dysfunction compared with sevoflurane-based general anesthesia

03

Conditions studied

  • Delirium
  • Postoperative Cognitive Dysfunction
04

Who can participate

Ages eligible
65 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age ≥ 65 years and \< 90 years;
  2. Scheduled to undergo non-cardiac or non-neurosurgery with an expected duration of 2 hours or more, under general anesthesia;
  3. Agree to participate, and give signed written .

Exclusion criteria

Exclusion Criteria:

  1. Preoperative history of schizophrenia, epilepsy, parkinsonism or any diseases of central nervous system;
  2. Inability to communicate in the preoperative period (coma, dementia, language barrier, impaired hearing or vision);
  3. Severe diseases in cardiovascular, respiratory, liver, kidney, or preoperative physical status classification ≥ IV;
  4. Alcoholism and drug dependence;
  5. Other reasons that are considered unsuitable for participation by the responsible surgeons or investigators (reasons must be recorded in the case report form).
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
890 participants (estimated)

Study arms

  • Active comparator
    Sevoflurane group

    Sevoflurane will be administered by inhalation for anesthesia maintenance. The concentration of inhaled sevoflurane will be adjusted to maintain the bispectral index (BIS) value between 40 and 60. Analgesia will be supplemented with remifentanil, sufentanil. Sevoflurane inhalation will be stopped at the end of surgery.

    Drug: Sevoflurane

  • Experimental
    Desflurane group

    Desflurane will be administered by inhalation for anesthesia maintenance. The concentration of inhaled sevoflurane will be adjusted to maintain the BIS value between 40 and 60. Analgesia will be supplemented with remifentanil, sufentanil. Desflurane inhalation will be stopped at the end of surgery.

    Drug: Desflurane

Interventions

  • Desflurane will be administered by inhalation for anesthesia maintenance. The concentration of inhaled desflurane will be adjusted to maintain the bispectral index (BIS) value between 40 and 60. Analgesia will be supplemented with remifentanil (administered by continuous infusion), and sufentanil (administered by intermittent injection).Towards the end of surgery, desflurane inhalational concentration will be decreased and sufentanil will be administered when necessary. Desflurane inhalation will be stopped at the end of surgery.

  • Sevoflurane will be administered by inhalation for anesthesia maintenance. The concentration of inhaled sevoflurane will be adjusted to maintain the bispectral index (BIS) value between 40 and 60. Analgesia will be supplemented with remifentanil (administered by continuous infusion), sufentanil (administered by intermittent injection).Towards the end of surgery, sevoflurane inhalational concentration will be decreased and sufentanil will be administered when necessary. Sevoflurane inhalation will be stopped at the end of surgery.

06

What researchers measure

Primary outcomes

  1. postoperative delirium

    Delirium is assessed twice daily with the Confusion Assessment Method for patients without endotracheal intubation or the Confusion Assessment Method for the Intensive Care Unit for patients with endotracheal intubation.

    Time frame: within 7 days after surgery

Secondary outcomes

  1. Quality of recovery, QoR15 (Quality of Recovery 15)

    Quality of recovery-15 questionnaire, which consists 15 questions. The score ranges from 0 to 150. The higher the score, the better the quality of recovery.

    Time frame: The day before surgery and on the 7th day after surgery or discharge

  2. Subjective sleep quality (NRS) within 3 days after surgery.

    Subjective sleep quality is assessed once daily with the Numeric Rating Scale (an 11-point rating scale where 0 = the worst sleep and 10 = the best sleep).

    Time frame: Up to 3 days after surgery

  3. Length of stay in hospital after surgery.

    Length of stay in hospital after surgery

    Time frame: Up to 30 days after surgery

  4. Percentage of intensive care unit (ICU) admission after surgery.

    Percentage of intensive care unit (ICU) admission after surgery

    Time frame: Within 24 hours after surgery

  5. Length of stay in ICU after surgery.

    Length of stay in ICU after surgery (in patients admitted to the ICU after surgery)

    Time frame: Up to 30 days after surgery

  6. Incidence of complications within 30 days

    Complications are defined as newly occurred events that are harmful to patients' recovery and required therapeutic intervention

    Time frame: Up to 30 days after surgery

  7. Intensity of pain within 3 days after surgery

    Intensity of pain is assessed twice daily (8-10 AM and 6-8 PM) with the Numeric Rating Scale (an 11-point rating scale where 0 = no pain and 10 = the worst pain).

    Time frame: Up to 3 days after surgery

  8. Incidence of postoperative cognitive dysfunction (POCD)

    Postoperative changes in Neuropsychological Tests score compared with baseline preoperative Neuropsychological Test scores in both the groups.

    Time frame: The day before surgery and on the 7th day after surgery or discharge

Other outcomes

  1. Cognitive function at 30 days after surgery

    Cognitive function assessed with Telephone Interview for Cognitive Status-Modified (TICS-m)

    Time frame: On the 30th day after surgery

  2. TNF-α concentration

    Blood specimens will be taken for measuring TNF-α, which is measured with liquid chromatography-mass spectrometry.

    Time frame: The day before surgery and 24 hours after surgery. Performed in part of enrolled patients.

  3. IL-6 concentration

    Blood specimens will be taken for measuring IL-6, which is measured with fluorescence immunochromatography

    Time frame: The day before surgery and 24 hours after surgery. Performed in part of enrolled patients.

07

Study locations

1 of 1 sites recruiting
  • Department of Anesthesiology, West China Hospital
    Chengdu, Sichuan 610041, China
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2023 (actual). Primary completion is estimated for Jul 2025, 22 months after the start.

Of 219 non-industry interventional studies with no phase under Delirium, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 45. This study's planned 22 months is below that.

Counting every sponsor, half of 222 studies reached it within 26 months; a quarter within 12 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 21, 2023
First posted
Dec 19, 2023
StartActual
Sep 10, 2023
Primary completionEst.
Jul 2025
CompletionEst.
Sep 2025
Last update
Jun 4, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 4, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06176144
Responsible party
Min Xu (Attending anesthesiologist,Department of Anesthesiology, West China Hospital, Sichuan University, West China Hospital) — Principal investigator
First posted
Dec 19, 2023
Start date
Sep 10, 2023
Primary completion
Jul 2025 (estimated)
Completion
Sep 2025 (estimated)
Last update
Jun 4, 2024

Study contacts

Jing Yang, MD,PhD
Contact
yangjing@wchscu.cn
+86- 18980602269
Min Xu
Contact
18706782887@163.com
+86-13281155917
Jing Yang, MD,PhD
principal investigator · West China Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Desflurane

Start the discussion